M

Mesoblast
MSB

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
A$2.29B
EV
A$2.43B
Shares Outstanding
1.30B
Beta
2.03

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
A$3.80
P/E 2025E
15.75x
P/Revenue 2025E
67.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Mesoblast Limited

gainify

M

Mesoblast Limited

MSB

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The ...

Sector

Healthcare

Industry

Biotechnology

CEO

Itescu, Silviu

Employees

73

IPO Date

2004-12-15

Headquarters

55 Collins Street, Level 38, Melbourne, Victoria, 3000, Australia

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved